In 2022, oncologist Dr. Armin Rashidi joined the Fred Hutchinson Cancer Center (FHCC) to treat patients who receive stem cell transplants for the treatment of blood-related cancers. A new study recently published in npj Biofilms and Microbiomes describes work his group has done to understand microbial predictors of treatment complication severity.

Dr. Siddarth Venkatesh, now at the Institute for Systems Biology in Seattle, previously studied the gut microbiome's impact on childhood undernutrition and the therapeutic potential of microbiota-directed complementary food (MDCF) at Washington University. The culmination of that work was published today in Science, where Dr. Venkatesh and coauthors describe a microbial fatty acid amide hydrolase that may be crucial for health in this context.

Results from a new study led by Drs. Qinqin Zhao and Joseph Mougous et al. uncovers a new modular proteinaceous antimicrobial particle produced by soil bacteria.

A new publication from Drs. Dustin Long and Steve Salipante et al. yields insight into the sources of surgical site infections during major spine surgery.